Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1990-5-14
|
pubmed:abstractText |
The cardiotoxic effect of the beta-adrenergic agonist isoproterenol was studied in cultured neonatal rat myocytes. A progressive increase in irreversible cell injury as determined by leakage of the cytoplasmic enzyme alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) from the cells was noted at concentrations above 2.5 x 10(-4) M isoproterenol (exposure time 6 h). The isoproterenol-induced cell damage was reduced or prevented by several free radical scavengers: the application of Trolox C, a water-soluble vitamin E analogue, ICRF-159, a chelator of divalent cations, ascorbic acid, a potent antioxidant, as well as the enzymatic free radical scavengers superoxide dismutase and catalase reduced alpha-HBDH release. This study corroborates the hypothesis that oxidation products of isoproterenol, especially the formation of oxygen- and/or oxygen-derived free radicals, are responsible for the cytotoxicity observed after prolonged exposure to isoproterenol. In contrast to isoproterenol, exposure to 5 x 10(-4) M fenoterol, another beta-adrenergic agonist which is not oxidized, does not impair the viability of the myocytes. Moreover, application of the beta-blocker propranolol (10(-4) M, 10(-5)M) in combination with 5 x 10(-4) M isoproterenol does not prevent alpha-HBDH release. These findings suggest that isoproterenol-induced cardiotoxicity is not the result of excessive beta-adrenoceptor activation, but is mediated by the formation of free radicals.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-hydroxybutyrate dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/Fenoterol,
http://linkedlifedata.com/resource/pubmed/chemical/Free Radicals,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxybutyrate Dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-2828
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1285-91
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2632811-Animals,
pubmed-meshheading:2632811-Cell Survival,
pubmed-meshheading:2632811-Cells, Cultured,
pubmed-meshheading:2632811-Fenoterol,
pubmed-meshheading:2632811-Free Radicals,
pubmed-meshheading:2632811-Heart,
pubmed-meshheading:2632811-Hydroxybutyrate Dehydrogenase,
pubmed-meshheading:2632811-Isoproterenol,
pubmed-meshheading:2632811-Myocardium,
pubmed-meshheading:2632811-Oxidation-Reduction,
pubmed-meshheading:2632811-Rats,
pubmed-meshheading:2632811-Rats, Inbred Strains
|
pubmed:year |
1989
|
pubmed:articleTitle |
Isoproterenol-induced cytotoxicity in neonatal rat heart cell cultures is mediated by free radical formation.
|
pubmed:affiliation |
Department of Cardiology, University Hospital, Leiden, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|